`
`
`
`UNITED STATES PATENT AND TRADEMARK OFFICE
`
`
`
`BEFORE THE PATENT TRIAL AND APPEAL BOARD
`
`
`
`MYLAN PHARMACEUTICALS INC.,
`Petitioner,
`
`
`v.
`
`SANOFI-AVENTIS DEUTSCHLAND GmbH,
`Patent Owner.
`
`
`Case IPR2018-01676
`Patent No. 8,603,044
`
`
`DECLARATION OF ROBERT T. VLASIS IN SUPPORT OF MOTION FOR
`PRO HAC VICE ADMISSION UNDER 37 C.F.R. § 42.10
`
`
`
`
`
`
`
`
`
`
`Sanofi Exhibit 2219.001
`Mylan v. Sanofi
`IPR2018-01676
`
`
`
`DECLARATION OF MR. ROBERT T. VLASIS IN SUPPORT OF MOTION
`FOR PRO HAC VICE ADMISSION
`
`I, Robert Vlasis, am over eighteen years of age and would be competent to
`
`testify as to the matters set forth herein if called upon to do so.
`
`1.
`
`I am an attorney in the law firm of Weil, Gotshal & Manges LLP. I
`
`have over a decade of experience as a patent litigator and have represented clients
`
`in numerous complex patent litigation cases in various United States District
`
`Courts, and before the Federal Circuit and the U.S. International Trade Comission.
`
`My biography is attached hereto as Ex. 2220.
`
`2.
`
`I am familiar with the subject matter at issue in this proceeding. I
`
`am counsel for Patent Owner in the co-pending litigation Sanofi-Aventis U.S. LLC
`
`v. Mylan N.V., Case No. 17-cv-9105 (D.N.J.), in which U.S. Patent No. 8,603,044
`
`was asserted in the complaint. I have been intimately involved with the subject
`
`matter at issue since the outset of these proceedings and the co-pending litigation.
`
`3.
`
`I am a member in good standing of the state bar of Texas, the
`
`District of Columbia, the United States Court of Appeals for the Federal Circuit,
`
`and the United States Supreme Court.
`
`4.
`
`I have not been suspended or disbarred from practice before any
`
`court or administrative body.
`
`5.
`
`I have never had an application for admission to practice before any
`
`court or administrative body denied.
`
`1
`
`Sanofi Exhibit 2219.002
`Mylan v. Sanofi
`IPR2018-01676
`
`
`
`
`
`6.
`
`No sanction or contempt citation has been imposed against me by
`
`any court or administrative body.
`
`7.
`
`I have read and will comply with the Office Patent Trial Practice
`
`Guide and the Board’s Rules of Practice for Trials set forth in part 42 of 37 C.F.R.
`
`8.
`
`I will be subject to the USPTO Rules of Professional Conduct set
`
`forth in 37 C.F.R. §§ 11.101 et seq. and disciplinary jurisdiction under 37 C.F.R. §
`
`11.19(a).
`
`9.
`
`Within the last three years, I have been admitted pro hac vice before
`
`the Patent Trial and Appeal Board in IPR2017-01526 and IPR2017-01528.
`
`
`
`I declare under penalty of perjury that the foregoing Declaration is true and
`
`correct; and further that these statements are made with the knowledge that willful
`
`false statements and the like are punishable by fine or imprisonment, or both, under
`
`Section 1001 of Title 18 of the United States Code.
`
`Dated: July 9, 2019
`
`
`
`
`
`
`
`
`Respectfully submitted,
`
`/Robert T. Vlasis/
`Robert T. Vlasis
`Weil, Gotshal & Manges LLP
`2001 M Street NW, Ste. 600
`Washington, D.C. 20036
`T: 202-682-7000
`robert.vlasis@weil.com
`
`2
`
`Sanofi Exhibit 2219.003
`Mylan v. Sanofi
`IPR2018-01676
`
`